Atlas Trials

Spinocerebellar Ataxia Type 3

21 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Spinocerebellar Ataxia Type 3

RecordFirmDate
STRIDES - a Clinical Research Study of an Investigational New Drug to Treat Spinocerebellar Ataxia (NCT05490563)Seelos Therapeutics, Inc.2022-06-03
A Pharmacokinetics and Safety Study of BIIB132 in Adults With Spinocerebellar Ataxia 3 (NCT05160558)Biogen2022-02-02
Efficacy Of Oral Trehalose In Spinocerebellar Ataxia 3 (NCT04399265)National University of Malaysia2020-02-24
Neuropsychiatry and Cognition in SCA3/MJD (NCT04714307)Hospital de Clinicas de Porto Alegre2019-12-13
Instrumented Data Exchange for Ataxia Study (NCT04268147)University of Chicago2019-06-01
Troriluzole in Adult Participants With Spinocerebellar Ataxia (NCT03701399)Biohaven Pharmaceuticals, Inc.2019-03-08
Identification of Biomarkers in Spinocerebellar Ataxia 3 (NCT03885167)University of Michigan2019-02-21
Repetitive Transcranial Magnetic Stimulation in SCA3 Patients (NCT05502432)Ning Wang, MD., PhD.2018-12-17
Astrocytic Markers and the Pre-ataxic Period of SCA3/MJD - BIGPRO Study Astrocytes (NCT04419974)Hospital de Clinicas de Porto Alegre2017-03-18
Safety and Efficacy of Lithium Carbonate in Patients With Spinocerebellar Ataxia Type 3 (NCT01096082)Hospital de Clinicas de Porto Alegre2011-05-01
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford (NCT01793168)Sanford Health2010-07-01
Pilot Study of Safety and Efficacy of Sodium Phenylbutyrate in Spinocerebellar Ataxia Type 3 (NCT01096095)Hospital de Clinicas de Porto Alegre2010-06-01
Natural History Study of and Genetic Modifiers in Spinocerebellar Ataxias (NCT01060371)Lauren Moore2010-04-01
Study to Determine the Safety and Tolerability of Varenicline (Chantix®) in Treating Spinocerebellar Ataxia Type 3 (NCT00992771)University of South Florida2009-10-01

Track Spinocerebellar Ataxia Type 3 automatically

Every clearance here is in the API, with alerts when new ones post.